150 related articles for article (PubMed ID: 7865456)
1. Transgenic mice expressing constitutive levels of IL-2 in islet beta cells develop diabetes.
Elliott EA; Flavell RA
Int Immunol; 1994 Nov; 6(11):1629-37. PubMed ID: 7865456
[TBL] [Abstract][Full Text] [Related]
2. Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response.
von Herrath MG; Allison J; Miller JF; Oldstone MB
J Clin Invest; 1995 Feb; 95(2):477-85. PubMed ID: 7860729
[TBL] [Abstract][Full Text] [Related]
3. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
5. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
6. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice.
DiCosmo BF; Picarella D; Flavell RA
Int Immunol; 1994 Dec; 6(12):1829-37. PubMed ID: 7696203
[TBL] [Abstract][Full Text] [Related]
7. Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
Hoyne GF; Flening E; Yabas M; Teh C; Altin JA; Randall K; Thien CB; Langdon WY; Goodnow CC
J Immunol; 2011 Feb; 186(4):2024-32. PubMed ID: 21248249
[TBL] [Abstract][Full Text] [Related]
8. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
9. Tracing the action of IL-2 in tolerance to islet-specific antigen.
Liston A; Siggs OM; Goodnow CC
Immunol Cell Biol; 2007 Jun; 85(4):338-42. PubMed ID: 17372610
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
Stephens LA; Kay TW
Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
[TBL] [Abstract][Full Text] [Related]
11. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
[TBL] [Abstract][Full Text] [Related]
13. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
14. Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event.
Anderson JT; Cornelius JG; Jarpe AJ; Winter WE; Peck AB
Autoimmunity; 1993; 15(2):113-22. PubMed ID: 8105989
[TBL] [Abstract][Full Text] [Related]
15. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.
Ablamunits V; Elias D; Cohen IR
Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451
[TBL] [Abstract][Full Text] [Related]
16. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
[TBL] [Abstract][Full Text] [Related]
17. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model.
Da Rosa LC; Boldison J; De Leenheer E; Davies J; Wen L; Wong FS
Diabetologia; 2018 Jun; 61(6):1397-1410. PubMed ID: 29594371
[TBL] [Abstract][Full Text] [Related]
18. Enhanced CD4
Dwyer AJ; Ritz JM; Mitchell JS; Martinov T; Alkhatib M; Silva N; Tucker CG; Fife BT
Sci Rep; 2021 Aug; 11(1):17142. PubMed ID: 34433860
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice.
Moritani M; Yoshimoto K; Tashiro F; Hashimoto C; Miyazaki J; Ii S; Kudo E; Iwahana H; Hayashi Y; Sano T
Int Immunol; 1994 Dec; 6(12):1927-36. PubMed ID: 7696210
[TBL] [Abstract][Full Text] [Related]
20. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
